[在门静脉血栓形成后诊断的V因子莱登原发性骨髓纤维化]
Akihiko Numata1, Takahiro Shima1, Takashi Jiromaru1
1Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences.
概括
本病例报告详细介绍了一例罕见的日本原发性骨髓纤维化 (PMF) 病例,该病例具有因子V莱登 (FVL) 突变. 早期诊断和鲁克索利提尼布治疗改善了患者的治疗结果,突出了综合血栓友爱症评估的必要性.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 原发性骨髓纤维化 (PMF) 是一种与血栓形成相关的骨髓扩散性瘤,通常通过JAK2 V617F突变.
- 因子V莱登 (FVL) 突变是高加索人常见的遗传性血栓友病,但在日本很少见.
- 门高血压和食道静脉可以呈现PMF的症状.
研究的目的:
- 在日本的一名美国患者中报告一种罕见的PMF病例,同时具有FVL突变.
- 为了说明这种罕见的并发症的诊断和治疗挑战.
- 强调在特定患者群体中彻底进行血栓友爱查看的重要性.
主要方法:
- 一名美国患者的病例报告,诊断出PMF呈门高血压.
- 基因检测证实了JAK2 V617F突变和FVL携带者身份.
- 治疗包括Ruxolitinib用于PMF症状和外科手术的术后管理.
主要成果:
- 卢克索利提尼布治疗导致腹壮大和门口高血压症状显著改善.
- 患者接受了成功的骨折手术,并有效地控制了血栓形成的风险.
- 这一案例突显了PMF和FVL在日本罕见的同时发生.
结论:
- 对MPN驱动突变和血栓性因素的全面评估对于非典型血栓形成至关重要,特别是在高加索患者中.
- 早期诊断和适当的治疗,包括向性治疗,如鲁克索利提尼布,可以改善PMF的结果.
- 这一案例强调了需要在不同患者群体中增加对罕见遗传血栓瘤的认识,这些患者群体呈现出骨髓增殖性瘤.
相关概念视频
Venous Thrombosis III: Interprofessional Care
428
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
428
Venous Thrombosis I: Introduction
599
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
599
Hepatic Portal System
7.0K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
7.0K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
405
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
405
Disorders of Hemostasis
2.5K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.5K
Esophageal Varices-II: Clinical Features and Management
697
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
697


